BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 36220303)

  • 1. Mast cell-T cell axis alters development of colitis-dependent and colitis-independent colorectal tumours: potential for therapeutically targeting via mast cell inhibition.
    Sakita JY; Elias-Oliveira J; Carlos D; de Souza Santos E; Almeida LY; Malta TM; Brunaldi MO; Albuquerque S; Araújo Silva CL; Andrade MV; Bonato VLD; Garcia SB; Cunha FQ; Cebinelli GCM; Martins RB; Matthews J; Colli L; Martin FL; Uyemura SA; Kannen V
    J Immunother Cancer; 2022 Oct; 10(10):. PubMed ID: 36220303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High tumor mast cell density is associated with longer survival of colon cancer patients.
    Mehdawi L; Osman J; Topi G; Sjölander A
    Acta Oncol; 2016 Dec; 55(12):1434-1442. PubMed ID: 27355473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of mucosal mast cells promotes inflammation-related colon cancer development through recruiting and modulating inflammatory CD11b(+)Gr1(+) cells.
    Xu L; Yi HG; Wu Z; Han W; Chen K; Zang M; Wang D; Zhao X; Wang H; Qu C
    Cancer Lett; 2015 Aug; 364(2):173-80. PubMed ID: 25986744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single-cell analysis unveils activation of mast cells in colorectal cancer microenvironment.
    Xie Z; Niu L; Zheng G; Du K; Dai S; Li R; Dan H; Duan L; Wu H; Ren G; Dou X; Feng F; Zhang J; Zheng J
    Cell Biosci; 2023 Nov; 13(1):217. PubMed ID: 38031173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Galectin-1 fosters an immunosuppressive microenvironment in colorectal cancer by reprogramming CD8
    Cagnoni AJ; Giribaldi ML; Blidner AG; Cutine AM; Gatto SG; Morales RM; Salatino M; Abba MC; Croci DO; Mariño KV; Rabinovich GA
    Proc Natl Acad Sci U S A; 2021 May; 118(21):. PubMed ID: 34006646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mast cells in colorectal cancer tumour progression, angiogenesis, and lymphangiogenesis.
    Liu X; Li X; Wei H; Liu Y; Li N
    Front Immunol; 2023; 14():1209056. PubMed ID: 37497234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blocking IL-17A enhances tumor response to anti-PD-1 immunotherapy in microsatellite stable colorectal cancer.
    Liu C; Liu R; Wang B; Lian J; Yao Y; Sun H; Zhang C; Fang L; Guan X; Shi J; Han S; Zhan F; Luo S; Yao Y; Zheng T; Zhang Y
    J Immunother Cancer; 2021 Jan; 9(1):. PubMed ID: 33462141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The critical role of mast cell-derived hypoxia-inducible factor-1α in regulating mast cell function.
    Liang X; Yin G; Ma Y; Xu K; Liu J; Li J
    J Pharm Pharmacol; 2016 Nov; 68(11):1409-1416. PubMed ID: 27671226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vam3, a Compound Derived from Vitis amurensis Rupr., Attenuated Colitis-Related Tumorigenesis by Inhibiting NF-κB Signaling Pathway.
    Xuan L; Jiang R; Wu Z; Yi H; Yao C; Hou Q; Qu C
    Front Pharmacol; 2016; 7():311. PubMed ID: 27679575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The mast cell-T lymphocyte axis impacts cancer: Friend or foe?
    Kannen V; Grant DM; Matthews J
    Cancer Lett; 2024 Apr; 588():216805. PubMed ID: 38462035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High density of tryptase-positive mast cells in human colorectal cancer: a poor prognostic factor related to protease-activated receptor 2 expression.
    Malfettone A; Silvestris N; Saponaro C; Ranieri G; Russo A; Caruso S; Popescu O; Simone G; Paradiso A; Mangia A
    J Cell Mol Med; 2013 Aug; 17(8):1025-37. PubMed ID: 23991686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mast Cells Infiltrating Inflamed or Transformed Gut Alternatively Sustain Mucosal Healing or Tumor Growth.
    Rigoni A; Bongiovanni L; Burocchi A; Sangaletti S; Danelli L; Guarnotta C; Lewis A; Rizzo A; Silver AR; Tripodo C; Colombo MP
    Cancer Res; 2015 Sep; 75(18):3760-70. PubMed ID: 26206557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mast cells inhibit colorectal cancer development by inducing ER stress through secreting Cystatin C.
    Song F; Zhang Y; Chen Q; Bi D; Yang M; Lu L; Li M; Zhu H; Liu Y; Wei Q; Qin H; Li J
    Oncogene; 2023 Jan; 42(3):209-223. PubMed ID: 36402931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mast Cell Tryptase Promotes Inflammatory Bowel Disease-Induced Intestinal Fibrosis.
    Liu B; Yang MQ; Yu TY; Yin YY; Liu Y; Wang XD; He ZG; Yin L; Chen CQ; Li JY
    Inflamm Bowel Dis; 2021 Jan; 27(2):242-255. PubMed ID: 32507895
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blockade of IDO-Kynurenine-AhR Axis Ameliorated Colitis-Associated Colon Cancer via Inhibiting Immune Tolerance.
    Zhang X; Liu X; Zhou W; Du Q; Yang M; Ding Y; Hu R
    Cell Mol Gastroenterol Hepatol; 2021; 12(4):1179-1199. PubMed ID: 34087454
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Abnormal interactions between perifollicular mast cells and CD8+ T-cells may contribute to the pathogenesis of alopecia areata.
    Bertolini M; Zilio F; Rossi A; Kleditzsch P; Emelianov VE; Gilhar A; Keren A; Meyer KC; Wang E; Funk W; McElwee K; Paus R
    PLoS One; 2014; 9(5):e94260. PubMed ID: 24832234
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential Immune Infiltration Profiles in Colitis-Associated Colorectal Cancer versus Sporadic Colorectal Cancer.
    Schardey J; Lu C; Neumann J; Wirth U; Li Q; Jiang T; Zimmermann P; Andrassy J; Bazhin AV; Werner J; Kühn F
    Cancers (Basel); 2023 Sep; 15(19):. PubMed ID: 37835436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In colorectal cancer mast cells contribute to systemic regulatory T-cell dysfunction.
    Blatner NR; Bonertz A; Beckhove P; Cheon EC; Krantz SB; Strouch M; Weitz J; Koch M; Halverson AL; Bentrem DJ; Khazaie K
    Proc Natl Acad Sci U S A; 2010 Apr; 107(14):6430-5. PubMed ID: 20308560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The omega-3 polyunsaturated fatty acid eicosapentaenoic acid inhibits mouse MC-26 colorectal cancer cell liver metastasis via inhibition of PGE2-dependent cell motility.
    Hawcroft G; Volpato M; Marston G; Ingram N; Perry SL; Cockbain AJ; Race AD; Munarini A; Belluzzi A; Loadman PM; Coletta PL; Hull MA
    Br J Pharmacol; 2012 Jul; 166(5):1724-37. PubMed ID: 22300262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TRIB3 Interacts With β-Catenin and TCF4 to Increase Stem Cell Features of Colorectal Cancer Stem Cells and Tumorigenesis.
    Hua F; Shang S; Yang YW; Zhang HZ; Xu TL; Yu JJ; Zhou DD; Cui B; Li K; Lv XX; Zhang XW; Liu SS; Yu JM; Wang F; Zhang C; Huang B; Hu ZW
    Gastroenterology; 2019 Feb; 156(3):708-721.e15. PubMed ID: 30365932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.